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smoking, hypertension, diabetes mellitus, obesity
(BMI & waist-hip ratio),~edentary habits, water
softness, type A person.ality , stress, iron overload ,
coffee drinking, CMV infection of arterial wall, genetic
factors have all been studied in detail but the first two
have been taken up with greater emphasis for
preventive modification? Abnormalities of
apolipoproteins esp. Apo a and E play an important
role in atherogenesis and increased incidence ofCHD.
These apolipoproteins are embedded in the surface of
lipoprotein particles and are encoded by the genes
on chromosomes 1,2,6, II and 198, Framingham and
other studies have clearly demonstrated higher
incidence of atherosclerosis and higher CHD mortality
with high serum cholesterol, LDL, VLDL and
triglycerides and the beneficial effect of lowering
these in prevention of coronary artery disease; while
elevated HDL is inversely related to Incidence of
atherosclerosis and its sequelae. Lower levels of
HDL are found in menopausal females, cigarette
smokers, obese, diabetics and those with sedentary
habits. Reg'ular aerobic. physical exercise,
individual ized, benefits lipid profi I e and
apolipoproteins 9a,b besides improving blood
viscosity and angiogenesis 10 . Various lipid lowering
drug therapies are beneficial and of these.HMG CoA
reductase inhibitors (Lovostatin) appear most
promising I I . Reversal of experimental athero'sclerosis
by cholesterol lowering drugs 12, calcium channel
blockers (Nifedipine)'Ja, probucol 13b, and omega - 3
fatty acids have been tried I3 c .
Cellular molecular biology and genetic
encoding studiesl4 have given a newer insight to the
understanding of the fundamental abnormalities
causing atherosclerosis, and the role of prostacyclin
(PG12), c - AMP, endothelium derived relaxation factor
(EDRF) [which appears to be nitric oxide (NO)] have
been studied extensively. From such studies newer
concepts in preventive aspect are being evovledl5•
An interesting observation was made in
Norway that all the 64 patients who died of premature
In developed coun~ries, coronary heart
disease (CHD) accounts for 40-50% of all deaths,
while 15-35% of all cardiac admissions in hospitals in
our country are due to coronary heart disease'. The
prevalence of CHD in our country varies from 1.7%
to 6.5%2 and is rising, affecting young and middle
aged persons in prime of their life and career 3a and
it is said that CHD will replace infectious diseases as
the major killer in India by year 2015 A.D.Jb. Indian
immigrants settled abroad have higher incidence and
higher mortality as compared to native population.
4a,b.The famous cardiologist Paul Dudley White has
said "Heart disease before the age 80 is not God's
wiH but due to our own faults" and it is the same
n.essage as given by Charaka about 30 centuries
back" in 1000 B.C., who emphasized the role of
overeating, heavy and fatty meals , worries and
sedentary habits in causation of heart disease5• The
human and economic costs of such a situation are
very heavy.
Atherosclerosis, the term introduced by
Marchand in 1904, is the lipid rich lesion in the
innermost layer of the arteries which is responsible
for the majority of cases of myocardial and cerebral
infarction. The endothelial lining of the artery is in
direct and continuous contact with blood and
interaction of blood cells & other constituents with
the endothelium gives rise to atherosclerosis. This
lesion presents as either fatty streak which is made
up offoam cells, lipids & T lymphocytes and occurs
early, commonly in children or fibrous plaque
consisting of dense connective tissue, lipid droplets,
smooth muscle cells, macrophages & T lymphocytes.
Platelets adhere and aggregate to ulcerated or
fissured plaques.6
The 'risk factor' concept evolved from the
epidemiologic and prospective studies of incidence
& progression of CHD in U.S.A. and Europe. The
non-modifiable risk factors like age, sex, and family
history and modifiable risk factors like
hyperlipidemia, (and dyslipidemia), cigarette
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Prevention of CHD is cheaper and a better
strategy could be:-
People with risk factors are identified by
med ica I check-u ps, who are then prescri bed'
individualized programmes directed at reducing or
eliminating'the risk factors and thus, preventing or
at least delaying the ,development of CHD20•
CHD had markedly elevated levels of amino-acid
homocysteine. Since then more than 50 papers have
been published confirming the findings that elevated
homocysteine level' appears to be another risk factor
making the patient 41/2 times more prone to death 16a,b.
Excess of homocysteine causes aggregation of blood
platelets, damage of intima, and deposition of lipids
. in the damaged area. Low levels of Vitamin B6 ' B12
and folic acid decrease the breakdown of circulating
homocysteine, thereby giving another prevention
strategy.
Although the clinical manifestations of
atherosclerosis appear in fourth decade or later, the
pathological process usual1y starts in childhood.
Therefore, the preventive programme directed at risk
factors should start early and continue through
adulthood and later years for effective prevention of
CHD. '
5
In secondary and tertiary prevention, those
persons who already are affected by CHD, the
programme is designed to lessen the mortality and
morbidity. This includes avoidance of cigarette
smoking, physical exercise, lowering oflipids by drugs
(& exercise), control of hypertension and diabetes
mellitus, low dose aspirin 21.22 a.b, appropriate drug
regimens, useof blockers (Metoprolol), 23
psychological rehabilitation, yoga & biofeed back
and surgical interventions like angioplasty, coronary
artery bypass grafting, transmyocardial
revascularization etc., if required, are underaken.
Prevention of coronary bypass graft occlusion is
possible with the use of statin group of drugs 2\
omega - 3 fatty acids 25, and anti-platelet therapy 26.27.
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Electronic Contraceptive
The world's first electronic contraceptive will go on sale after being tested by 1500 women in
England, Irish Republic & Germany. The contraceptive is said to be a suitablealtemative to pills with no
health risk. Its reliability falls between that of condoms (88%) and pills (92.8%). The system provides
computer guided advice, displaying a green light, when it is safe to have sex. Since it is not a physical device,
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